SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-008299
Filing Date
2014-11-17
Accepted
2014-11-17 06:04:39
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0914_yewbiopharm.htm 10-Q 651138
2 CERTIFICATION f10q0914ex31i_yewbiopharm.htm EX-31.1 7106
3 CERTIFICATION f10q0914ex31ii_yewbiopharm.htm EX-31.2 7117
4 CERTIFICATION f10q0914ex32_yewbiopharm.htm EX-32 2980
  Complete submission text file 0001213900-14-008299.txt   4878158

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE yewb-20140930.xml EX-101.INS 694992
6 XBRL SCHEMA FILE yewb-20140930.xsd EX-101.SCH 53485
7 XBRL CALCULATION FILE yewb-20140930_cal.xml EX-101.CAL 39399
8 XBRL DEFINITION FILE yewb-20140930_def.xml EX-101.DEF 103051
9 XBRL LABEL FILE yewb-20140930_lab.xml EX-101.LAB 386742
10 XBRL PRESENTATION FILE yewb-20140930_pre.xml EX-101.PRE 238436
Mailing Address 294 POWERBILT AVENUE LAS VEGAS NV 89148
Business Address 294 POWERBILT AVENUE LAS VEGAS NV 89148 86-0451-82292379
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54701 | Film No.: 141226256
SIC: 0100 Agricultural Production-Crops